A detailed history of Geode Capital Management, LLC transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,291,286 shares of MTNB stock, worth $8.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,291,286
Previous 2,135,457 7.3%
Holding current value
$8.11 Million
Previous $576,000 36.46%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.15 - $0.37 $23,374 - $57,656
155,829 Added 7.3%
2,291,286 $366,000
Q1 2024

May 13, 2024

BUY
$0.19 - $0.3 $106,199 - $167,683
558,944 Added 35.45%
2,135,457 $576,000
Q4 2023

Feb 13, 2024

SELL
$0.12 - $0.64 $46,077 - $245,746
-383,979 Reduced 19.59%
1,576,513 $346,000
Q3 2023

Nov 13, 2023

BUY
$0.12 - $0.41 $184 - $631
1,540 Added 0.08%
1,960,492 $254,000
Q2 2023

Aug 11, 2023

BUY
$0.35 - $0.72 $53,932 - $110,947
154,094 Added 8.54%
1,958,952 $705,000
Q4 2022

Feb 13, 2023

BUY
$0.46 - $42.69 $52,744 - $4.89 Million
114,662 Added 6.78%
1,804,858 $902,000
Q3 2022

Nov 14, 2022

BUY
$0.63 - $33.0 $87,576 - $4.59 Million
139,010 Added 8.96%
1,690,196 $1.07 Million
Q2 2022

Aug 12, 2022

SELL
$0.63 - $0.96 $50,079 - $76,311
-79,491 Reduced 4.87%
1,551,186 $1.23 Million
Q1 2022

May 13, 2022

BUY
$0.5 - $1.06 $21,907 - $46,442
43,814 Added 2.76%
1,630,677 $1.31 Million
Q4 2021

Feb 11, 2022

BUY
$0.92 - $1.22 $176,749 - $234,385
192,119 Added 13.77%
1,586,863 $1.6 Million
Q3 2021

Nov 12, 2021

BUY
$0.67 - $1.51 $50,775 - $114,435
75,785 Added 5.75%
1,394,744 $1.81 Million
Q2 2021

Aug 13, 2021

BUY
$0.75 - $1.1 $39,782 - $58,347
53,043 Added 4.19%
1,318,959 $1.02 Million
Q1 2021

May 12, 2021

BUY
$0.96 - $1.74 $138,801 - $251,577
144,585 Added 12.89%
1,265,916 $1.33 Million
Q4 2020

Feb 12, 2021

BUY
$0.76 - $1.47 $31,856 - $61,616
41,916 Added 3.88%
1,121,331 $1.53 Million
Q1 2020

May 14, 2020

BUY
$0.6 - $2.31 $126,361 - $486,492
210,603 Added 24.24%
1,079,415 $647,000
Q4 2019

Feb 13, 2020

BUY
$0.63 - $2.27 $40,396 - $145,556
64,122 Added 7.97%
868,812 $1.97 Million
Q3 2019

Nov 12, 2019

BUY
$0.59 - $0.9 $72,191 - $110,122
122,358 Added 17.93%
804,690 $507,000
Q1 2019

May 14, 2019

BUY
$0.6 - $1.41 $165,359 - $388,594
275,599 Added 67.76%
682,332 $743,000
Q3 2018

Nov 13, 2018

SELL
$0.35 - $0.92 $655 - $1,722
-1,872 Reduced 0.46%
406,733 $374,000
Q2 2018

Aug 14, 2018

SELL
$0.42 - $0.74 $56,783 - $100,047
-135,199 Reduced 24.86%
408,605 $177,000
Q1 2018

May 15, 2018

BUY
$0.76 - $1.32 $11,116 - $19,307
14,627 Added 2.76%
543,804 $415,000
Q4 2017

Feb 13, 2018

BUY
$1.1 - $1.54 $30,373 - $42,522
27,612 Added 5.51%
529,177 $613,000
Q3 2017

Nov 14, 2017

BUY
$1.19 - $1.43 $7,548 - $9,070
6,343 Added 1.28%
501,565 $662,000
Q2 2017

Aug 14, 2017

BUY
N/A
495,222
495,222 $836,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $768M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.